RedC Biotech
Universal Red Blood Cells for Life Saving Transfusions and Advanced Therapies
Company Overview
Snapshot
Founded in April 2015 by Ari Gargir, RedC Biotech operates with 1–10 employees. The company has secured $3M in total capital across four funding rounds from one investor. In March 2022, RedC Biotech received a grant, highlighting its ongoing development in the biotechnology sector.
Business overview
RedC Biotech is a preclinical development-stage company focused on creating universal red blood cells from stem cells using a patented cultivation technology. This highly scalable process aims to meet the global demand for safe red blood cell transfusions, providing a blood type suitable for almost every patient with potency comparable to currently used transfusions. The company operates within the Health Tech & Life Sciences sector, specifically targeting the pharmaceutical and medical biotechnology industries with a B2B business model.
Strategic signal
In June 2022, RedC Biotech was featured for its innovative approach to producing donor-less blood in the lab to alleviate shortages. This signals a significant advancement in addressing critical global healthcare needs, demonstrating the company's potential to revolutionize blood transfusion practices and reduce reliance on traditional blood donations, which could attract further investment and strategic partnerships in the life sciences sector.
Log in to access full profile ›Company Intelligence Q&A
- What is RedC Biotech's primary focus?
- RedC Biotech is dedicated to developing universal red blood cells from stem cells using a patented cultivation technology, aiming to provide a safe and scalable solution for blood transfusions worldwide.
- When was RedC Biotech founded?
- RedC Biotech was founded in April 2015.
- Who is the founder of RedC Biotech?
- Ari Gargir is the founder of RedC Biotech.
- What was a notable recognition for RedC Biotech in March 2022?
- In March 2022, Ari Gargir from RedC Biotech won the Ziv Aviram Fund competition in Dubai.
- What was a key development for RedC Biotech in June 2022?
- In June 2022, RedC Biotech was recognized for producing donor-less blood in a lab to address blood shortages, showcasing its innovative approach to blood supply.